InvestorsHub Logo

IgnoranceIsBliss

02/15/20 8:28 PM

#246637 RE: biowreck #246635

Yes except that the uptake oz promised hasn’t come to bear fruit like he envisioned....


I think we have to keep in mind that it is February of 2020.

I don't think anyone said that this would be sudden.

I do think there will be a tipping point... and inflection where sales growth kicks into a second gear. I think the time from $1bn to $3bn will be shorter than the time from $500mm to $1bn.

The Irishman

02/15/20 10:25 PM

#246647 RE: biowreck #246635

biowreck... the uptake?
I don’t know you or your background. So, I will not question your expertise. Having said that, I will share this thought: Rome wasn’t built in a day. Meaning, the uptake will come. If you expected a complete 180 right after the new indication then you don’t understand medicine, clinician habit and the importance of frequency of message in the pharmaceutical industry. It is quite rare for any drug to achieve blockbuster status within its first year. I mentioned on a previous post a couple of weeks ago that it takes 7 sales calls to begin to change the prescribing habit of a clinician. Not to completely change their prescribing, but to get them to move from no usage to trialing the medication. These reps just started. Give it time. The frequency of message will take root.

Be well